ATLANGRAM is specializing in preclinical efficacy testing of antibacterial agents thanks to its comprehensive In vitro and In vivo studies (screening & discriminant models). Thus, we can provide recommendations on optimal dose, on administration route and/or frequency, and finally, on bacterial targets and future development/indications of the compound.
Our offer is comprehensive and consists of a wide range of microbiology studies to assess in vitro and in vivo efficacy activities of an antibacterial agent.
20+ years Efficacy Expertise
500+ Characterized Strains
12+ Mouse & Rabbit Models
We use the Nano-Encapsulation in Lipid Nano-Capsules (LNCs), an innovative technology to improve antibacterial efficacy and tolerance.
Stealth and Biodegradable
Safe and non-expensive
ATLANGRAM is based at Nantes (France), a city which offers opportunities to conduct collaborative projects with the Nantes University, MedQual (an epidemiological network with a bank of hospital and community bacterial strains), and Atlanpole Biotherapies (a regional cluster). Bpifrance, the Region Pays de la Loire and Total Development have granted to ATLANGRAM a financial assistance.
ATLANGRAM scientific team has published in international scientific journals (PLoS One, AAC, JAC etc.) and communicated at various conferences such as ICAAC, ASM and ECCMID. Here are our last publications.